ArticlePloS one2024

Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines.

PLOS ONE EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.